Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Other Non-Current Liabilities (2019 - 2025)

AVITA Medical (RCEL) has disclosed Other Non-Current Liabilities for 5 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities fell 63.78% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Dec 2025, down 63.78%, and an annual FY2025 reading of $1.2 million, down 63.78% over the prior year.
  • Other Non-Current Liabilities was $1.2 million for Q4 2025 at AVITA Medical, down from $1.9 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $4.0 million in Q1 2024 and bottomed at $571000.0 in Q1 2022.
  • Average Other Non-Current Liabilities over 4 years is $2.2 million, with a median of $1.9 million recorded in 2024.
  • The sharpest move saw Other Non-Current Liabilities soared 134.27% in 2023, then crashed 63.78% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $1.3 million in 2022, then soared by 134.27% to $3.2 million in 2023, then increased by 8.68% to $3.4 million in 2024, then plummeted by 63.78% to $1.2 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for RCEL at $1.2 million in Q4 2025, $1.9 million in Q3 2025, and $1.9 million in Q2 2025.